INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS

被引:146
作者
BAUER, LA [1 ]
EDWARDS, WAD [1 ]
DELLINGER, EP [1 ]
SIMONOWITZ, DA [1 ]
机构
[1] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195
关键词
D O I
10.1007/BF00542215
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:643 / 647
页数:5
相关论文
共 22 条
[1]   OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION [J].
ABERNETHY, DR ;
DIVOLL, M ;
GREENBLATT, DJ ;
AMEER, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) :783-790
[2]  
ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
[3]   DIGOXIN DISPOSITION IN OBESITY - CLINICAL PHARMACOKINETIC INVESTIGATION [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
SMITH, TW .
AMERICAN HEART JOURNAL, 1981, 102 (04) :740-744
[4]   PREDICTABILITY OF BLOOD-LEVELS OF GENTAMICIN IN MAN [J].
BARZA, M ;
BROWN, RB ;
SHEN, D ;
GIBALDI, M ;
WEINSTEIN, L .
JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (02) :165-174
[5]   AMIKACIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].
BAUER, LA ;
BLOUIN, RA ;
GRIFFEN, WO ;
RECORD, KE ;
BELL, RM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04) :519-522
[6]   TOBRAMYCIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].
BLOUIN, RA ;
MANN, HJ ;
GRIFFEN, WO ;
BAUER, LA ;
RECORD, KE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :508-512
[7]   VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS [J].
BLOUIN, RA ;
BAUER, LA ;
MILLER, DD ;
RECORD, KE ;
GRIFFEN, WO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :575-580
[8]   THEOPHYLLINE CLEARANCE - EFFECT OF MARKED OBESITY [J].
BLOUIN, RA ;
ELGERT, JF ;
BAUER, LA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (05) :619-623
[9]   GENTAMICIN THERAPY [J].
DEVINE, BJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655
[10]   ESTIMATING CREATININE CLEARANCE IN MORBIDLY OBESE PATIENTS [J].
DIONNE, RE ;
BAUER, LA ;
GIBSON, GA ;
GRIFFEN, WO ;
BLOUIN, RA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (06) :841-844